We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01646593
Recruitment Status : No longer available
First Posted : July 20, 2012
Last Update Posted : December 15, 2014
Sponsor:
Information provided by:
Bayer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : No longer available
  Primary Completion Date : No date given
  Study Completion Date : No date given